Pulmonx Corporation Skyrocketed
Mon, Aug 03, 2026 at 06:56 PM
Pulmonx Corporation (LUNG:NASDAQ) rocketted at $2.12, representing a gain of 30.1%. On Mon, Aug 03, 2026, LUNG:NASDAQ hit a New 2-Week High of $2.12. The stock appeared on our News Catalysts scanner on Sat, Aug 01, 2026 at 12:53 AM in the 'EARNINGS' category. From Mon, Jul 20, 2026, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Fri, Mar 06, 2026 at $2.16 with a volume of 4M+.
About Pulmonx Corporation (LUNG:NASDAQ)
ProLung Inc is a medical technology company which has developed lung cancer risk test called as ProLung Test to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography (CT) scan.
Top 10 Gainers:
- Reitar Logtech Holdings Limited (RITR:NASDAQ), 495.47%
- Hydrofarm Holdings Group, Inc. (HYFM:NASDAQ), 298.15%
- T3 Defense Inc Com New (DFNS:NASDAQ), 122.18%
- Universe Pharmaceuticals INC (UPC:NASDAQ), 99.38%
- Megan Holdings Limited (MGN:NASDAQ), 87.23%
- Fusemachines Inc. (FUSE:NASDAQ), 69.64%
- Reliance Global Group Inc. (EZRA:NASDAQ), 45.6%
- Golden Sun Health Technology Group Limited (GSUN:NASDAQ), 44.76%
- Universal Logistics Holdings, Inc. (ULH:NASDAQ), 36.1%
- Pulmonx Corporation (LUNG:NASDAQ), 30.06%